Selective Lysine Ubiquitination Using Activated Phenol Esters
ChemBioChem · 2025
DOI: 10.1002/cbic.202500266 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Halana C Vlaming und 9 weiteren Autor:innen. Beteiligte Einrichtung: Dept. Cell and Chemical Biology, Leiden University Medical Centre, 2333 ZC, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Lysine, Esters, Ubiquitin, Phenols. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NWO, European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie, European Research Council.
Abstract (Originalsprache)
Ubiquitination of target proteins is an essential post‐translational modification influencing a wide variety of cellular processes. Herein, the use of a novel water‐soluble acylation reagent based on the 2,4‐dichloro‐6‐sulfonic acid phenol ester of ubiquitin is described for efficient and selective ubiquitin modification of peptides. Under alkaline conditions, this reagent is swift and regioselective toward lysine acylation, while at neutral pH it shows loss of regioselectivity and is able to acylate both lysine and N‐terminal modification at reduced speeds. As proof of concept, a model peptide is utilized to demonstrate this strategy, proving to be successful. Then the ubiquitination of a synthetic protein called Fau gene encoded Ubiquitin‐like protein (FUBI) is performed under alkaline conditions followed by tandem MS analysis, proving that the selective lysine ubiquitination works to prepare protein–protein conjugates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dept. Cell and Chemical Biology, Leiden University Medical Centre, 2333 ZC, Leiden, The Netherlands.
- Global Research Technologies, Novo Nordisk A/S, Novo Nordisk Research Park, DK-2760, Måløv, Denmark.
- Centre for Proteomics and Metabolomics, Leiden University Medical Centre, 2300 RC, Leiden, The Netherlands.
- CMC API Development, Novo Nordisk A/S, Novo Nordisk Park, DK-2880, Bagsvaerd, Denmark.
ORCID-Profile: Halana C Vlaming, Yara Huppelschoten, Rayman T N Tjokrodirijo, Peter A van Veelen, Francesca D'Amico, Kim B Jensen, Thomas E Nielsen, Bhavesh Premdjee, Gerbrand J van der Heden van Noort
Förderung
- NWO
- European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie
- European Research Council
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- H2020 European Research Council
Zitieren
APA
Vlaming, H. C., Huppelschoten, Y., Tjokrodirijo, R. T. N., van Veelen, P. A., D'Amico, F., Jensen, K. B., Buchardt, J., Nielsen, T. E., Premdjee, B., & van der Heden van Noort, G. J. (2025). Selective Lysine Ubiquitination Using Activated Phenol Esters. ChemBioChem. https://doi.org/10.1002/cbic.202500266
Vancouver
Vlaming HC, Huppelschoten Y, Tjokrodirijo RTN, van Veelen PA, D'Amico F, Jensen KB, et al. Selective Lysine Ubiquitination Using Activated Phenol Esters. ChemBioChem. 2025. doi:10.1002/cbic.202500266
BibTeX
@article{Vlaming2025,
author = {Vlaming, Halana C and Huppelschoten, Yara and Tjokrodirijo, Rayman T N and van Veelen, Peter A and D'Amico, Francesca and Jensen, Kim B and Buchardt, Jens and Nielsen, Thomas E and Premdjee, Bhavesh and van der Heden van Noort, Gerbrand J},
title = {Selective Lysine Ubiquitination Using Activated Phenol Esters},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202500266}
}
EUVIMED